GIM
Granahan Investment Management Portfolio holdings
AUM
$2.07B
1-Year Est. Return
56.45%
This Fund
S&P 500
1 Year Est. Return
+56.45%
AUM
$2.34B
AUM Growth
-$107M
(-4.4%)
Holding
173
Top Buys
| 1 | +$25.7M | |
| 2 | +$23.5M | |
| 3 | +$21M | |
| 4 |
Modine Manufacturing
MOD
|
+$20.8M |
| 5 |
Sterling Infrastructure
STRL
|
+$20.4M |
Top Sells
| 1 | +$61.6M | |
| 2 | +$34.2M | |
| 3 | +$28.2M | |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$18M |
| 5 |
Descartes Systems
DSGX
|
+$16.3M |
Sector Composition
| 1 | Technology | 28.03% |
| 2 | Industrials | 20.41% |
| 3 | Healthcare | 14.38% |
| 4 | Financials | 12.85% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Kiniksa Pharmaceuticals
KNSA
$4.1B
| $13M | 0.56% |
316,213
+32,642
|
|
||
52
Archer Aviation
ACHR
$4.85B
| $12.9M | 0.55% |
1,713,170
-1,226,930
|
|
||
53
SharkNinja
SN
$15.9B
| $12.6M | 0.54% |
112,863
+27,274
|
|
||
|
BETA
54
Beta Technologies Inc
BETA
$3.87B
| $12.4M | 0.53% |
+438,351
|
|
||
55
Repligen
RGEN
$6.49B
| $11.8M | 0.51% |
72,002
+2,131
|
|
||
56
OrthoPediatrics
KIDS
$472M
| $11.8M | 0.51% |
663,981
-95,970
|
|
||
57
BioLife Solutions
BLFS
$1.17B
| $11.7M | 0.5% |
482,356
+90,260
|
|
||
58
Universal Technical Institute
UTI
$2.21B
| $11.5M | 0.49% |
439,252
+315,006
|
|
||
59
Owlet
OWLT
$168M
| $11.1M | 0.48% |
686,749
+176,845
|
|
||
60
Transcat
TRNS
$681M
| $10.9M | 0.47% |
191,580
-36,985
|
|
||
61
Lumentum
LITE
$73.7B
| $10.5M | 0.45% |
28,498
-4,383
|
|
||
|
STKL
62
DELISTED
SunOpta
STKL
| $10.1M | 0.43% |
2,670,652
-57,599
|
|
||
63
Xeris Biopharma Holdings
XERS
$1.07B
| $9.6M | 0.41% |
1,223,404
+873,236
|
|
||
64
JFrog
FROG
$8.96B
| $9.41M | 0.4% |
150,580
-13,895
|
|
||
|
JBTM
65
JBT Marel
JBTM
$6.87B
| $9.35M | 0.4% |
62,044
-1,321
|
|
||
66
Immunome
IMNM
$2.45B
| $9.35M | 0.4% |
435,123
+8,904
|
|
||
67
Celcuity
CELC
$6.74B
| $8.68M | 0.37% |
87,032
+37,751
|
|
||
68
HealthEquity
HQY
$7.39B
| $8.34M | 0.36% |
+91,020
|
|
||
69
Viking Therapeutics
VKTX
$3.59B
| $8.29M | 0.35% |
235,586
+46,057
|
|
||
70
Revolution Medicines
RVMD
$32.2B
| $7.9M | 0.34% |
99,194
-19,498
|
|
||
71
Nutanix
NTNX
$12.7B
| $7.86M | 0.34% |
152,001
-21,108
|
|
||
72
BridgeBio Pharma
BBIO
$13.5B
| $7.79M | 0.33% |
101,805
-59,473
|
|
||
73
Syndax Pharmaceuticals
SNDX
$1.77B
| $7.71M | 0.33% |
366,793
-29,543
|
|
||
74
Kinsale Capital Group
KNSL
$7.15B
| $7.7M | 0.33% |
19,686
+4,064
|
|
||
75
Apogee Therapeutics
APGE
$6.12B
| $7.15M | 0.31% |
94,720
-37,680
|
|